Drug Type Biological products |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | CA | 04 Nov 2019 | |
Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | US | 04 Nov 2019 | |
Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | IL | 04 Nov 2019 | |
Relapsed Solid Neoplasm | Phase 1 | US | 04 Nov 2019 | |
Relapsed Solid Neoplasm | Phase 1 | CA | 04 Nov 2019 | |
Relapsed Solid Neoplasm | Phase 1 | IL | 04 Nov 2019 | |
Unresectable Melanoma | Phase 1 | CA | 04 Nov 2019 | |
Unresectable Melanoma | Phase 1 | IL | 04 Nov 2019 | |
Unresectable Melanoma | Phase 1 | US | 04 Nov 2019 |
Phase 1 | 35 | (Dose Expansion Arm A, Melanoma) | qrobkvtdvg(bqriyqvsfw) = xtkaivxegd coinqbauux (gywuztizkf, endorhemxb - quqiirqhvj) View more | - | 12 Nov 2024 | ||
(Dose Expansion Arm B, HNSCC) | qrobkvtdvg(bqriyqvsfw) = exsgrcwzhk coinqbauux (gywuztizkf, hpchgcvcxf - unhogbnzgl) View more |